KRAS G12C Lung Cancer trials recruiting in Iowa

Fewer than 3 recruiting trials found.

All KRAS G12C Lung Cancer trials nationally

1

Recruiting in Iowa

2

Cities with sites

Cities in Iowa

Des Moines 1Iowa City 1

Recruiting trials in Iowa

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
NCT06793215 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Iowa: Des Moines, Iowa City

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.